Loading insider details...
Latest Form 4 (Oct 22, 2026): Grant/Award of 795 VRTX shares, $400.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 22, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 795 | $400.3K |
| Jun 18, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/Award | 404 | n/a |
| Feb 28, 2026 | WATERS CORP /DE/ (WAT) | Grant/Award | 23 | n/a |
| Jan 5, 2026 | WATERS CORP /DE/ (WAT) | Grant/Award | 307 | n/a |
| Aug 5, 2025 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/Award | 967 | n/a |
| Feb 19, 2025 | BOSTON SCIENTIFIC CORP (BSX) | Sale | 2,900 | $301.8K |
| Feb 18, 2025 | BOSTON SCIENTIFIC CORP (BSX) | Exercise/Conversion | 4,362 | n/a |
| Feb 14, 2025 | BOSTON SCIENTIFIC CORP (BSX) | Exercise/Conversion | 3,654 | n/a |
| Feb 13, 2025 | BOSTON SCIENTIFIC CORP (BSX) | Grant/Award | 33,944 | n/a |
| Jan 6, 2025 | WATERS CORP /DE/ (WAT) | Grant/Award | 319 | n/a |